Uterine artery doppler
Diagnostic TestUterine artery Doppler pulsatility indices
NCT Number: NCT03440281
Study included all pregnant women admitted with threatened preterm labor during the study period. All participants underwent estimation of maternal serum homocysteine level and assessment of uterine artery Doppler indices.
Looking for future studies?
Notify Me18 year–35 year
Female
Observational
Prospective cohort study. Study approval by local ethics committee. Informed written consent. Study included all pregnant women admitted with threatened preterm labor during the study period. All participants underwent estimation of maternal serum homocysteine level and assessment of uterine artery Doppler indices.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Uterine artery Doppler pulsatility indices
Time frame: Single measurement at the end of the study ( around 37 gestational weeks)
Sensitivity (%), specificity (%), positive predictive value (%), negative predictive value (%), positive likelihood ratio (number), negative likelihood ratio (number), accuracy (%) of serum homocysteine and UtA-PI for prediction of preterm labor
Time frame: Single measurement at the end of the study ( around 37 gestational weeks)
Gestational age at delivery (Weeks),
Time frame: Single measurement on the day one of hospital admission between 28-35 gestational weeks
Maternal age (year), Body mass index (kilogram per squared meter), Gestational age at admission (Weeks), Maternal serum Homocysteine level ( micromoles/liter), uterine artery pulsatility index ( number)
Benha University
Other
Maternal Serum Homocysteine Levels and Uterine Artery Pulsatility Index as Predictors of Spontaneous Preterm Labor
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05994443
Female Urogenital Diseases and Pregnancy Complications, Maternal Psychological Distress
Montreal, Quebec, Canada
View Trial DetailsNCT04584814
Apnea of Newborn, Female Urogenital Diseases and Pregnancy Complications
Santiago, Santiago Metropolitan, Chile
View Trial DetailsNCT00855543
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Charleston, West Virginia, United States
View Trial DetailsNCT07336173
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Kafr ash Shaykh, Egypt
View Trial Details